Product
Tetanus Toxoid
2 clinical trials
2 indications
Indication
TetanusIndication
Brain NeoplasmsClinical trial
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of GR2001 Injection in Healthy SubjectsStatus: Completed, Estimated PCD: 2023-11-01
Clinical trial
Anti-Tumor Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed Glioblastoma Multiforme During Recovery From Therapeutic Temozolomide-induced LymphopeniaStatus: Completed, Estimated PCD: 2017-04-15